timolol has been researched along with Adverse Drug Event in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (27.78) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 4 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Akmalova, KA; Fisenko, VP; Grishina, EA; Ivashchenko, DV; Kachanova, AA; Moshetova, LK; Soshina, MM; Sozaeva, ZA; Sychev, DA; Turkina, KI; Zastrozhin, MS | 1 |
| Bachmann, LM; Jensen, BP; Müller, L; Wells, AP; Wong, D | 1 |
| Li, H; Lin, Z; Yu, Z; Zhang, B | 1 |
| Dahle, SE; Gallegos, A; Isseroff, RR; Kaur, R; Schaefer, S; Tchanque-Fossuo, C; West, K; Yang, H; Yoon, DJ | 1 |
| Li, Y; Zheng, L | 1 |
| Baudouin, C; Belkacem, S; Derdour, A; Garout, R; Ghroud, N; Kherroubi, R; Lazreg, S; Merad, Z; Meziane, M; Nouri, MT; Ouhadj, O; Tiar, M | 1 |
| Akhtar, M; Alaei, M; Kausar, H; Najmi, AK | 1 |
| Lorenz, K; Pfeiffer, N | 1 |
| Januleviciene, I | 1 |
| Clark, BG; Vestal, RE | 1 |
| Quigley, HA | 1 |
| Fraunfelder, FT | 1 |
| Magnus, D; Patorgis, CJ | 1 |
4 review(s) available for timolol and Adverse Drug Event
| Article | Year |
|---|---|
The effectiveness and safety of topical β-receptor blocker in treating superficial infantile haemangiomas: A meta-analysis including 20 studies.
Topics: Administration, Topical; Adrenergic beta-Antagonists; China; Drug-Related Side Effects and Adverse Reactions; Hemangioma, Capillary; Humans; Propranolol; Timolol | 2020 |
Effect of topical timolol on response rate and adverse events in infantile hemangioma: a meta-analysis.
Topics: Administration, Topical; Clinical Trials as Topic; Drug-Related Side Effects and Adverse Reactions; Hemangioma; Humans; Infant, Newborn; Infant, Newborn, Diseases; Placebo Effect; Propranolol; Timolol | 2018 |
Efficacy and safety of tafluprost 0.0015% and timolol maleate 0.5% fixed combination in patients with ocular hypertension or open-angle glaucoma.
Topics: Antihypertensive Agents; Drug Combinations; Drug Evaluation; Drug-Related Side Effects and Adverse Reactions; Glaucoma; Glaucoma, Open-Angle; Humans; Ocular Hypertension; Prostaglandins F; Timolol | 2014 |
Brinzolamide 1%/timolol 0.5%: safety and efficacy of a new fixed-combination IOP-lowering product for glaucoma.
Topics: Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Glaucoma; Humans; Intraocular Pressure; Sulfonamides; Thiazines; Timolol; Treatment Outcome | 2010 |
2 trial(s) available for timolol and Adverse Drug Event
| Article | Year |
|---|---|
New technique to reduce systemic side effects of timolol eye drops: The tissue press method-Cross-over clinical trial.
Topics: Administration, Ophthalmic; Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Bradycardia; Cross-Over Studies; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Dyspnea; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Male; Middle Aged; Nasolacrimal Duct; Ocular Absorption; Ophthalmic Solutions; Timolol | 2020 |
Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications.
Topics: Adult; Aged; Aged, 80 and over; Algeria; Antihypertensive Agents; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Female; Gels; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Preservatives, Pharmaceutical; Timolol; Tonometry, Ocular; Treatment Outcome; Young Adult | 2018 |
12 other study(ies) available for timolol and Adverse Drug Event
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effect of
Topics: Adrenergic beta-Antagonists; Cytochrome P-450 CYP2D6; Drug-Related Side Effects and Adverse Reactions; Glaucoma; Glaucoma, Open-Angle; Humans; Polymorphism, Single Nucleotide; Timolol | 2023 |
Adverse effects of topical timolol: Safety concerns and implications for dermatologic use.
Topics: Adrenergic beta-Antagonists; Drug-Related Side Effects and Adverse Reactions; Humans; Off-Label Use; Patient Selection; Skin Diseases; Timolol | 2021 |
A prospective research study of anti-glaucoma drugs prescribing, utilization pattern and adverse drug reaction recording in a university hospital.
Topics: Acetazolamide; Adult; Adverse Drug Reaction Reporting Systems; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Female; Glaucoma; Hospitals, University; Humans; Latanoprost; Male; Middle Aged; Prospective Studies; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol | 2015 |
Adverse drug reactions in the elderly: case studies.
Topics: Acetazolamide; Aged; Anemia, Hemolytic; Bromocriptine; Captopril; Chlorpropamide; Cimetidine; Clonidine; Dienestrol; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydralazine; Lung Diseases; Male; Middle Aged; Nitrofurantoin; Pancreatitis; Papaverine; Peripheral Nervous System Diseases; Procainamide; Propranolol; Sulindac; Theophylline; Timolol | 1984 |
A reevaluation of glaucoma management.
Topics: Acetazolamide; Cataract; Costs and Cost Analysis; Drug-Related Side Effects and Adverse Reactions; Endophthalmitis; Epinephrine; Glaucoma; Humans; Middle Aged; Patient Compliance; Pilocarpine; Postoperative Complications; Tachyphylaxis; Time Factors; Timolol; Trabecular Meshwork; Visual Acuity | 1984 |
Adverse Drug Reactions Advisory Committee: ADRAC report for 1980.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Australia; Bronchial Spasm; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Corneal Diseases; Drug Evaluation; Drug Packaging; Drug-Related Side Effects and Adverse Reactions; Dyspnea; Female; Glaucoma; Humans; Infant; Infant, Newborn; Liver Diseases; Male; Mianserin; Middle Aged; Neutropenia; Nonprescription Drugs; Timolol; Valproic Acid | 1982 |
Interim report: National Registry of possible Drug-induced Ocular Side Effects.
Topics: Contact Lenses; Drug-Related Side Effects and Adverse Reactions; Eye Diseases; Fluorouracil; Humans; Ibuprofen; Methotrexate; Neomycin; Practolol; Registries; Sterilization; Tamoxifen; Timolol; United States; United States Food and Drug Administration | 1980 |
New drug therapy in open-angle glaucoma.
Topics: Betaxolol; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Glaucoma, Open-Angle; Humans; Nadolol; Patient Compliance; Propanolamines; Timolol | 1986 |